The FDA OK'd Acutus' real-time cardiac mapping system that monitors a patient’s atrial fibrillation during ablation.
OptiScan Biomedical scored an FDA nod for its bedside device that continuously monitors ICU patients’ glucose levels.
The complex and intertwined dual epidemics of poorly treated pain and opioid addiction require a combined, artful approach to secure the best possible results…
The green light marks the arrival of a rare new entrant to the field of abdominal surgery robotics.
The FDA has expanded the clearance of NuVasive’s limb-lengthening system to include bone transport.
The device’s standout feature is its accompanying 3D planning software designed to cut treatment times and lower costs.
The lawsuit alleges that Patrick Miles schemed for more than a year to badmouth NuVasive and build a stake in Alphatec.
Shockwave's new financing will expand commercialization of its ultrasound balloon treatment for calcified artery disease and boost R&D.
The FDA cleared an implant that stimulates a nerve in the chest that prompts the diaphragm to restore breathing.
LivaNova snagged FDA approvals for a pair of devices for the treatment of drug-resistant epilepsy.
Novartis’ Alcon earned a CE mark for its automated, disposable, preloaded intraocular lens delivery system.